Search clinical trials for: vulvar atrophy

Total 3367 results

Bioscience Cosmetics SL
Eurofins

Not yet recruiting

Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation

Vulvar Atrophy

France, Poland
New York Stem Cell Foundation Research Institute

Recruiting

NYSCF Scientific Discovery Biobank

PTSD | Multiple Sclerosis | Cervical Cancer | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Macular Degeneration | Diabetes Mellitus, Type 1 | Parkinson Disease | Amyotrophic Lateral Sclerosis | Dementia | Ovarian Cancer | Alzheimer Disease | ALS | Vulvar Cancer | Post Traumatic Stress Disorder | Lewy Body Disease and other conditions

United States
Stratpharma AG

Recruiting

VALOR: Vaginal Atrophy & Long-term Observation of Recovery (VALOR)

Atrophic Vaginitis | Vaginal Atrophy | Lichen Sclerosus of Vulva | Genitourinary Syndrome of Menopause | Lichen Planus of Vulva | Lichen Simplex of Vulva (Disorder)

United States
KDRS ltd

Recruiting

Vulvar Disease in Nigeria Observational Study (VdiN)

Vulvar Diseases | Vulvar Atrophy | Dermatoses

United Kingdom
Kanuni Sultan Suleyman Training and Research Hospital

Not yet recruiting

Genital Laser Treatment in Postmenopausal Patients

Menopause | Dyspareunia | Sexual Activity | Atrophy Vulva

Turkey
Dr. Santiago Palacios

Recruiting

Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain (ROSA)

Vulvovaginal Atrophy

Spain
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Recruiting

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2) (EPMLARF)

Breast Cancer | Vaginal Atrophy | Vulva; Atrophy

Brazil
Sunnybrook Health Sciences Centre
Innovation Fund of the Alternative Funding Plan from the Academic Health...

Recruiting

Laser Vaginal Treatment for GSM

Vulvar Atrophy | Menopausal Urethral Atrophy

Canada
Prasco LLC

Completed

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

Vulvar and Vaginal Atrophy

United States
Daré Bioscience, Inc.

Completed

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA (DARE-VVA1)

Vulvar Atrophy

Australia
Liaquat University of Medical & Health Sciences
University of Roma La Sapienza

Completed

Natural Topical Treatment for Vulvar and Vaginal Atrophy

Genitourinary Syndrome of Menopause

Italy
ASCEND Therapeutics
Solvay Pharmaceuticals

Completed

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Postmenopausal Symptoms

United States
Hospital Italiano de Buenos Aires

Terminated

The Use of Laser in the Treatment of Atrophic Vulvovaginitis

Lasers | Atrophy of Vagina | Atrophy Vulva

Argentina
Lallemand Health Solutions
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health (MPS)

Menopause

United States
GTO Pharmaceutical, LLC

Terminated

Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment

Female Sexual Dysfunction | Vulvovaginal Atrophy | Vulvodynia | Dyspareunia | Vestibulodynia | Postmenopausal Symptoms | Arousal Disorders, Sexual | Genito-Pelvic Pain/Penetration Disorder | Female Sexual Arousal Disorder | Sexual Pain Disorders

United States
Laboratoires Vivacy

Completed

Evaluation of the Efficacy and Safety of Hyaluronic Acid Injection in Labia Majora for Volume Restoration (ESOLANE)

Vulvar Atrophy

France
Candela Corporation

Completed

The CO2RE® System for Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus

United States
Mylan Pharmaceuticals Inc

Completed

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Atrophic Vaginitis

United States
Hospital Clinic of Barcelona

Completed

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors (VIBRA)

Breast Cancer | Genitourinary Syndrome of Menopause | Vulvar Atrophy

Spain
Padagis LLC
Impax Laboratories, LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

Atrophy

United States
Aspen USA Inc

Withdrawn

A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy (DOVE)

Vaginal Atrophy
Lumenis Be Ltd.

Unknown

Evaluation of the Safety and Efficacy of the NuEra Tight VRF for the Treatment of Vaginal and Vulvar Tissue Laxity

Vagina Atrophy

United States
Regen Lab SA

Completed

Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness

Vulvar Atrophy

France
Hadassah Medical Organization

Completed

Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus

Vaginal Atrophy | Lichen Sclerosus

Israel
Sun Pharmaceutical Industries Limited

Terminated

Efficacy and Safety Of Spil's Estradiol Vaginal Tablet

Vaginal Atrophy | Vulvar Atrophy

India
Petra Larmo
Turun Gynekologikeskus Oy; Tekes - The Finnish Funding Agency for Technology...

Completed

Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes

Vaginal Atrophy | Vaginal Dryness | Vulvar Atrophy | Vulvar Dryness

Finland
Shionogi
QuatRx Pharmaceuticals

Completed

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Atrophy | Vaginal Diseases
Shionogi
QuatRx Pharmaceuticals

Completed

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

Atrophy | Vaginal Diseases
Shionogi
Hormos Medical; QuatRx Pharmaceuticals

Completed

Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity

Atrophy | Vaginal Diseases
Shionogi
Hormos Medical; QuatRx Pharmaceuticals

Completed

A Clinical Study to Evaluate the Safety of Ospemifene

Atrophy | Vaginal Diseases
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

Vulvar and Vaginal Atrophy

United States
EndoCeutics Inc.

Completed

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

Vaginal Atrophy

United States, Canada
EndoCeutics Inc.

Completed

Topical DHEA Against Vaginal Atrophy

Vaginal Atrophy

United States, Canada
EndoCeutics Inc.

Completed

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

Vaginal Atrophy

United States, Canada
EndoCeutics Inc.

Completed

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

Vaginal Atrophy

United States, Canada
TherapeuticsMD

Completed

Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women (REJOICE)

Menopause | Vulvovaginal Atrophy | Dyspareunia | Painful Intercourse

United States, Canada
TherapeuticsMD

Completed

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

Menopause | Vulvovaginal Atrophy | Dyspareunia | Painful Intercourse

United States
Shionogi
Hormos Medical; QuatRx Pharmaceuticals

Completed

A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Atrophy | Vaginal Diseases
Shionogi
Hormos Medical; QuatRx Pharmaceuticals

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women

Atrophy | Vaginal Diseases
Bionovo

Unknown

VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women

Vaginal Atrophy | Vulvar Atrophy

United States
Imperial College London
University of Central Lancashire; University of Nottingham; Cancer Research UK; University of Birmingham and other collaborators

Recruiting

Cancer Loyalty Card Study 2 (CLOCS-2) ((CLOCS-2))

Stomach Cancer | Pancreatic Cancer | Ovarian Cancer | Vulvar Cancer | Bladder Cancer | Endometrial Cancer | Colon Cancer | Liver Cancer | Oesophageal Cancer | Uterine Cancer

United Kingdom
Cairo University

Not yet recruiting

Radiographic Assessment of Bone Gain Following Sinus Lifting With Simultaneous Implant Placement Using Crestal Approach With Membrane Control Technique for Bone Augmentation of Atrophied Maxillary Posterior Ridge

Implant Site Reaction | Maxillary Deficiency
Cairo University

Recruiting

Tenting Abutment Technique Versus Screw"Tent-Pole" Technique for Augmentation of Posterior Atrophic Mandible

Posterior Atrophic Mandible

Egypt
Azienda Ospedaliero Universitaria Maggiore della...

Not yet recruiting

Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity (Westernage)

Obesity | Sarcopenia

Italy
Gonzalo Blasi

Recruiting

The Influence of Non-Carious Cervical Lesions on Root Coverage

Gingival Recession

Spain
Ankara City Hospital Bilkent

Recruiting

Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis

Psoriatic Arthritis

Turkey
CellinCells

Not yet recruiting

Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101

Atrophic Scar
Postgraduate Institute of Dental Sciences Rohtak

Not yet recruiting

Chorion Membrane With Photobiostimulation ,Chorion Membrane & SCTG in Treating Isolated RT 2 Recession Defects

Gingival Recession

India
Postgraduate Institute of Dental Sciences Rohtak

Not yet recruiting

MCAT Versus VISTA With Volume Stable Collagen Matrix in RT3 Gingival Recession

Gingival Recession

India
Beni-Suef University

Recruiting

Bone Augmentation Using Calvarial Versus Iliac Crest Bone Blocks.

Bone Atrophy

Egypt

Search clinical trials for: vulvar atrophy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations